Literature DB >> 29803125

Neuromechanical response to passive cyclic loading of the ACL in non-professional soccer players: A pilot study.

Stefano Nuccio1, Luciana Labanca1, Jacopo Emanuele Rocchi2, Andrea Macaluso2, Paola Sbriccoli3.   

Abstract

OBJECTIVE: To investigate the effects of passive cyclic loading (CYC) on anterior tibial translation (ATT), knee extensor and flexor muscle strength and activation in soccer players.
DESIGN: Cross-sectional study.
SETTING: Functional Assessment Laboratory; Participants: Eight healthy competitive soccer players.
INTERVENTIONS: The knee of the dominant limb was subjected to 10 min of CYC at 200 N force. MAIN OUTCOMES MEASURES: ATT was measured before and after CYC. Percentage of variation was used to estimate ACL creep. Knee extension and flexion maximal voluntary contractions (MVCs) were assessed both before and after CYC. EMG amplitudes of both Biceps Femoris (BF) and Vastus Lateralis (VL) were recorded during both MVCs and CYC.
RESULTS: There was a 20.7% increase in ATT after CYC application (p<0.001). Post-CYC agonist and antagonist BF activations were 37.7% and 18.4% lower than pre-CYC ones during MVCs (p<0.05). BF EMG activity in the last 30s of CYC was 19.9% higher than in the first 30s (p<0.05).
CONCLUSION: The increased ATT and the variations in neuromuscular activation of the BF in response to loading may expose the knee at higher injury risk by increasing joint instability. Further studies are required to thoroughly investigate these aspects in both laboratory and real-field settings.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EMG; Functional stability; Injury prevention; Knee laxity

Mesh:

Year:  2018        PMID: 29803125     DOI: 10.1016/j.ptsp.2018.05.013

Source DB:  PubMed          Journal:  Phys Ther Sport        ISSN: 1466-853X            Impact factor:   2.365


  1 in total

1.  Static loading of the knee joint results in modified single leg landing biomechanics.

Authors:  Michael W Olson
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.